P. Albéric, River backflooding into a karst resurgence (Loiret, France), Journal of Hydrology, vol.286, issue.1-4, pp.194-202, 2004.
DOI : 10.1016/j.jhydrol.2003.09.018

P. Albéric and M. Lepiller, Oxidation of organic matter in a karstic hydrologic unit 489 supplied through stream sinks, Water Res, vol.3297, pp.7-2051, 1998.

O. S. Al-khazrajy and A. B. Boxall, Impacts of compound properties and sediment characteristics on the sorption behaviour of pharmaceuticals in aquatic systems, Journal of Hazardous Materials, vol.317, pp.198-209, 2016.
DOI : 10.1016/j.jhazmat.2016.05.065

C. A. Almeida, . De, M. S. Oliveira, C. A. Mallmann, and A. F. Martins, Determination of 495 the psychoactive drugs carbamazepine and diazepam in hospital effluent and 496 identification of their metabolites Analyse des ventes de médicaments en France en 2013, Available from: 499 http, ANSM_Analyse- 500 Ventes-Medicaments_2013.pdf, pp.17192-17201, 2015.

L. Barron, J. Havel, M. Purcell, M. Szpak, B. Kelleher et al., Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial neural networks, The Analyst, vol.39, issue.4, pp.663-670, 2009.
DOI : 10.1021/es702959a

F. Behar, V. Beaumont, and H. D. Penteado, Rock-Eval 6 Technology: Performances and Developments, Oil & Gas Science and Technology, vol.56, issue.2, pp.111-134, 2001.
DOI : 10.2516/ogst:2001013
URL : http://doi.org/10.2516/ogst:2001013

E. S. Bernhardt, E. J. Rosi, and M. O. Gessner, Synthetic chemicals as agents of global change, Frontiers in Ecology and the Environment, vol.351, issue.2, pp.84-90, 2017.
DOI : 10.1126/science.aad2622

B. Blair, A. Nikolaus, C. Hedman, R. Klaper, and T. Grundl, Evaluating the degradation, sorption, and negative mass balances of pharmaceuticals and personal care products during wastewater treatment, Chemosphere, vol.134, pp.395-401, 2015.
DOI : 10.1016/j.chemosphere.2015.04.078

A. B. Boxall, L. Fogg, P. A. Blackwell, P. Kay, and E. J. Pemberton, Review of 513 veterinary medicines in the environment, Environment Agency Bristol, p.514, 2002.

T. Brodin, J. Fick, M. Jonsson, and J. Klaminder, Dilute Concentrations of a Psychiatric Drug Alter Behavior of Fish from Natural Populations, Science, vol.123, issue.9, pp.814-8151226850, 2013.
DOI : 10.1289/ehp.1104477

F. Busetti, M. Ruff, and K. L. Linge, Target screening of chemicals of concern in recycled water, Environ. Sci.: Water Res. Technol., vol.45, issue.5, pp.659-667, 2015.
DOI : 10.1016/j.watres.2014.12.042

S. Chauveau, Médicament et société en France au 20e siècle. Vingtième Siècle Rev, p.520, 2002.
DOI : 10.2307/3772129

D. Silva, B. F. Jelic, A. López-serna, R. Mozeto, A. A. Petrovic et al., Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain, Chemosphere, vol.85, issue.8, pp.1331-1339, 2011.
DOI : 10.1016/j.chemosphere.2011.07.051

C. G. Daughton and T. A. Ternes, Pharmaceuticals and personal care products in the 526 environment: agents of subtle change? Environ. Health Perspect, 1999.

D. Castro-català, N. Kuzmanovic, M. Roig, N. Sierra, J. Ginebreda et al., Ecotoxicity of 530 sediments in rivers: Invertebrate community, toxicity bioassays and the toxic unit 531 approach as complementary assessment tools, Sci. Total Environ, vol.540, pp.324-333, 2016.

D. Jongh, C. M. Kooij, P. J. De-voogt, P. Ter-laak, and T. L. , Screening and human health 534 risk assessment of pharmaceuticals and their transformation products in Dutch surface 535 waters and drinking water, Sci. Total Environ, pp.427-428, 2012.

F. Arnaud, I. Bentaleb, E. Chapron, and . Others, Spectrocolorimetric interpretation 539 of sedimentary dynamics: the new " Q7/4 diagram, Earth-Sci. Rev, vol.109, 2011.

P. Drillia, K. Stamatelatou, and G. Lyberatos, Fate and mobility of pharmaceuticals in 542 solid matrices, Chemosphere, vol.60, 2005.

N. Dubois and J. Jacob, Molecular Biomarkers of Anthropic Impacts in Natural Archives: A Review, Frontiers in Ecology and Evolution, vol.41, issue.154, 2016.
DOI : 10.1016/j.orggeochem.2009.12.008
URL : https://hal.archives-ouvertes.fr/insu-01365745

M. L. Farré, S. Pérez, L. Kantiani, and D. Barceló, Fate and toxicity of emerging 552 pollutants, their metabolites and transformation products in the aquatic environment, p.553, 2008.

J. Fick, H. Söderström, R. H. Lindberg, C. Phan, M. Tysklind et al., 555 Contamination of surface, ground and drinking water from pharmaceutical production, p.556, 2009.

. Geo-hyd, Available 558 from: [WWW Document, 2009.

T. Heberer, Tracking persistent pharmaceutical residues from municipal sewage to drinking water, Journal of Hydrology, vol.266, issue.3-4, pp.175-189, 2002.
DOI : 10.1016/S0022-1694(02)00165-8

J. M. Hollis, Mapping the vulnerability of aquifers and surface waters to pesticide 563 contamination at the national/regional scale, Pestic. Soils Water BCPC Monogr, vol.47, issue.564, pp.165-174, 1991.

P. M. Bradley, Understanding the hydrologic impacts of wastewater treatment 567 plant discharge to shallow groundwater: before and after plant shutdown, Env. Sci, vol.568, 2016.

F. Ingerslev and B. Halling-sørensen, Biodegradability of metronidazole, olaquindox, and 570 tylosin and formation of tylosin degradation products in aerobic soil--manure slurries, p.571, 2001.

E. Joigneaux, Etat qualitatif des eaux de la nappe du val d'Orléans : impact du 573 changement climatique et gestion durable de la ressource, p.574, 2011.

R. G. Keil, D. B. Montlucon, and F. G. Prahli, Sorptive preservation of labile organic matter 575 in marine sediments, Nature, vol.370, issue.18, 1994.

J. Klaminder, T. Brodin, A. Sundelin, N. J. Anderson, J. Fahlman et al., Long-term persistence of an anxiolytic drug (oxazepam) in a large freshwater 578 lake, Environ. Sci. Technol, vol.577, issue.49, pp.2015-10406

M. W. Lam, C. J. Young, R. A. Brain, D. J. Johnson, M. A. Hanson et al., AQUATIC PERSISTENCE OF EIGHT PHARMACEUTICALS IN A MICROCOSM STUDY, Environmental Toxicology and Chemistry, vol.23, issue.6, pp.1431-144003, 2004.
DOI : 10.1897/03-421

J. Lienert, K. Güdel, and B. I. Escher, Screening Method for Ecotoxicological Hazard Assessment of 42 Pharmaceuticals Considering Human Metabolism and Excretory Routes, Environmental Science & Technology, vol.41, issue.12, pp.4471-4478, 2007.
DOI : 10.1021/es0627693

D. Löffler, J. Römbke, M. Meller, and T. A. Ternes, Environmental Fate of Pharmaceuticals in Water/Sediment Systems, Environmental Science & Technology, vol.39, issue.14, pp.5209-5218, 2005.
DOI : 10.1021/es0484146

R. Loos, B. M. Gawlik, G. Locoro, E. Rimaviciute, S. Contini et al., EU- 590 wide survey of polar organic persistent pollutants in European river waters, p.591, 2009.

B. Lopez, P. Ollivier, A. Togola, N. Baran, and J. Ghestem, Screening of French 593 groundwater for regulated and emerging contaminants, Sci. Total Environ, vol.594, pp.518-519, 2015.

C. Lorgeoux, R. Moilleron, J. Gasperi, S. Ayrault, P. Bonté et al., 596 Temporal trends of persistent organic pollutants in dated sediment cores: Chemical 597 fingerprinting of the anthropogenic impacts in the Seine River basin, 2016.

G. Mceneff, L. Barron, B. Kelleher, B. Paull, and B. Quinn, A year-long study of the 600 spatial occurrence and relative distribution of pharmaceutical residues in sewage 601 effluent, receiving marine waters and marine bivalves, Sci. Total Environ, vol.602, pp.476-477, 2014.

S. Mompelat, L. Bot, B. Thomas, and O. , Occurrence and fate of pharmaceutical products 604 and by-products, from resource to drinking water, Environ. Int, vol.35, 2009.

B. Petrie, R. Barden, and B. Kasprzyk-hordern, A review on emerging contaminants in 607 wastewaters and the environment: Current knowledge, understudied areas and 608 recommendations for future monitoring, Water Res, vol.72, 2015.

M. Schaffer, N. Boxberger, H. Börnick, T. Licha, and E. Worch, Sorption influenced 611 transport of ionizable pharmaceuticals onto a natural sandy aquifer sediment at 612 different pH, Chemosphere, vol.87, 2012.

F. Tamtam, L. Bot, B. Dinh, T. Mompelat, S. Eurin et al., A 50-year record of quinolone and sulphonamide 618 antimicrobial agents in Seine River sediments, J. Soils Sediments, vol.617, issue.11, pp.852-859, 2011.

F. Tamtam, F. Mercier, L. Bot, B. Eurin, J. Tuc-dinh et al., Occurrence and fate of antibiotics in the Seine River in various hydrological 622 conditions, Sci. Total Environ, vol.621, issue.393, pp.84-95, 2008.

K. G. Taylor and P. N. Owens, Sediments in urban river basins: a review of sediment?contaminant dynamics in an environmental system conditioned by human activities, Journal of Soils and Sediments, vol.16, issue.316, pp.281-303, 2009.
DOI : 10.1007/s11368-009-0103-z

T. Thiebault, M. Boussafir, R. Guégan, L. Milbeau, C. et al., Clayey?sand filter for the removal of pharmaceuticals from wastewater effluent: percolation experiments, Environ. Sci.: Water Res. Technol., vol.39, issue.245, pp.529-538, 2016.
DOI : 10.1039/C6EW00034G
URL : https://hal.archives-ouvertes.fr/insu-01298757

T. Thiebault, L. Fougère, E. Destandau, M. Réty, and J. Jacob, Temporal dynamics of 634 human-excreted pollutants in wastewater treatment plant influents: Toward a better 635 knowledge of mass load fluctuations, Sci. Total Environ, vol.596597, pp.246-255, 2017.

J. Tunkel, P. H. Howard, R. S. Boethling, W. Stiteler, and H. Loonen, Predicting ready 638 biodegradability in the Japanese ministry of international trade and industry test, p.639, 2000.

P. Souhaut, M. Lansard, B. Bourquin, M. Reyss, J. Von-ballmoos et al., Sources and Effects of Ionizing Radiation LAFARA: a new underground laboratory in the French Pyrénées for ultra 643 low-level gamma-ray spectrometry, Environ. Toxicol. Chem. J. Environ. Radioact, vol.19, issue.116, pp.2478-2485, 2000.

P. Välitalo, A. Kruglova, A. Mikola, and R. Vahala, Toxicological impacts of antibiotics 646 on aquatic micro-organisms: A mini-review, Int. J. Hyg. Environ. Health, 2017.

P. Vazquez-roig, V. Andreu, C. Blasco, and Y. Picó, Risk assessment on the presence of pharmaceuticals in sediments, soils and waters of the Pego???Oliva Marshlands (Valencia, eastern Spain), Science of The Total Environment, vol.440, pp.24-32, 2012.
DOI : 10.1016/j.scitotenv.2012.08.036

P. Verlicchi, A. Aukidy, M. Zambello, and E. , Occurrence of pharmaceutical compounds 653 in urban wastewater: Removal, mass load and environmental risk after a secondary 654 treatment?A review, Sci. Total Environ, vol.429, 2012.

P. Verlicchi, A. Galletti, M. Petrovic, and D. Barceló, Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options, Journal of Hydrology, vol.389, issue.3-4, pp.416-428, 2010.
DOI : 10.1016/j.jhydrol.2010.06.005

A. Wick, G. Fink, A. Joss, H. Siegrist, and T. A. Ternes, Fate of beta blockers and 666 psycho-active drugs in conventional wastewater treatment, Water Res, vol.43, 2009.

C. Summerhayes, M. Wagreich, M. Williams, A. P. Wolfe, and Y. Yonan, The 671 geological cycle of plastics and their use as a stratigraphic, p.672, 2016.

. Anthropocene, Anthropocene 13

J. Zhou and N. Broodbank, Sediment-water interactions of pharmaceutical residues in the river environment, Water Research, vol.48, pp.61-70, 2014.
DOI : 10.1016/j.watres.2013.09.026